Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01758523 · ClinicalTrials.gov registry record · Phase 4
Dutasteride Treatment for the Reduction of Heavy Drinking in Men
A Phase 4 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 189
- Enrollment target
NCT01758523 is a Phase 4 study that has completed, run by UConn Health. The registered enrollment target is 189 participants.
The verdict
NCT01758523, a Phase 4 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 189 participants
- Enrollment target
Study Summary
This study will examine the safety and potential benefit of the medication dutasteride to help men reduce or stop drinking alcohol.
Interventions
- DRUG Dutasteride
- DRUG sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-02-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01758523
The ClinicalTrials.gov registry entry for NCT01758523 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dutasteride is the first listed.
NCT01758523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01758523 about?
NCT01758523 is a clinical study titled "Dutasteride Treatment for the Reduction of Heavy Drinking in Men". This study will examine the safety and potential benefit of the medication dutasteride to help men reduce or stop drinking alcohol.
What is the current status of trial NCT01758523?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 189 participants. The study started on 2013-01. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT01758523?
The interventions under investigation include: Dutasteride (DRUG), sugar pill (DRUG).
Who is sponsoring clinical trial NCT01758523?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.